Lymphoma|omicsgroup|journal Of Integrative Oncology

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Lymphoma Scholarly Journals

OMICS Group consists of Open Access Scholarly Journals and OMICS group conferences. Through its Scholarly Open Access Initiative is committed to make genuine and trustworthy contributions to the people who are doing research in the respective fields. OMICS Group hosts over 700+ peer-reviewed journals and organize over 3000+ International Scientific Conferences annually all over the world. OMICS International journals have over 15 million readers and the reputation and success of the same can be attributed to the strong editorial board which contains over 50,000+ editorial board members that ensure a rapid, quality and quick review process. Lymphoma is a cancer of a part of the immune system called the lymph system. There are many types of lymphoma. One type is Hodgkin disease. The rest are called non-Hodgkin lymphomas. Non-Hodgkin lymphomas begin when a type of white blood cell, called a T cell or B cell, becomes abnormal. The cell divides again and again, making more and more abnormal cells. These abnormal cells can spread to almost any other part of the body. Most of the time, doctors don't know why a person gets non-Hodgkin lymphoma. You are at increased risk if you have a weakened immune system or have certain types of infections. Abnormal hair development and regeneration occurs in some skin diseases, including lymphomas when hair follicles are eliminated. Otherwise, neoplastic cells, both malignant and benign, local occurring and metastatic, can cause alopecia of the scalp. In lymphomas alopecia can develop due to direct infiltration by the disease, or it may be a secondary or paraneoplastic manifestation. Total -body hair loss can be diagnosed only in those with generalized erythroderma in mycosis fungoides and Sézary syndrome. Patchy alopecia clinically identical to alopecia areata is revealed in 34% patients suffering from mycosis fungoides or Sézary syndrome. Discreet patch/plaque or follicular lesions is observed within mycosis fungoides lesions in 66%. The involvement of hair follicles usually presents in folliculotropic mycosis fungoides. 65% of patients have alopecia. Follicular mucinosis is frequent in folliculotropic mycosis fungoides. Alopecia is also observed in ichthyosiform mycosis fungoides, syringotropic cutaneous T-cell lymphoma panniculitis-like T-cell lymphoma, primary cutaneous follicle center lymphoma Occipital alopecia areata, occipital and parietal alopecia were observed in B- cell lymphoma. Alopecia is a rare manifestation of Hodgkin’s disease. Alopecia may develop due to therapy and can be even a sign of therapeutical efficacy.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on January, 2021